MARKSANS PHARMA
Back to Balance Sheet
|
MARKSANS PHARMA Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Deferred Tax Assets / Liabilities | ₹3.66 Cr | ₹11 Cr | ₹15 Cr | ₹14 Cr | ₹7.26 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of MARKSANS PHARMA ?
| Year | Deferred Tax Assets / Liabilities |
|---|---|
| Mar2025 | ₹3.66 Cr |
| Mar2024 | ₹11 Cr |
| Mar2023 | ₹15 Cr |
| Mar2022 | ₹14 Cr |
| Mar2021 | ₹7.26 Cr |
How is Deferred Tax Assets / Liabilities of MARKSANS PHARMA Trending?
| Years | Deferred Tax Assets / Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹3.66 Cr | -65.52 | |
| Mar2024 | ₹11 Cr | -30.98 | |
| Mar2023 | ₹15 Cr | 11.78 | |
| Mar2022 | ₹14 Cr | 89.48 | |
| Mar2021 | ₹7.26 Cr | - | |
Compare Deferred Tax Assets / Liabilities of peers of MARKSANS PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| MARKSANS PHARMA | ₹7,704.4 Cr | 2.2% | -3% | -25% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹412,326.0 Cr | -5.7% | -3.3% | -2.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹155,282.0 Cr | -3.1% | -9.3% | 0% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹137,043.0 Cr | -6.1% | -8.3% | 23.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹99,854.2 Cr | -5.1% | -6% | 4.8% | Stock Analytics | |
| CIPLA | ₹97,115.7 Cr | -3.3% | -11.2% | -19.5% | Stock Analytics | |
MARKSANS PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| MARKSANS PHARMA | 2.2% |
-3% |
-25% |
| SENSEX | 1.4% |
-7% |
-3.9% |
You may also like the below Video Courses